Drugs Targeting Tumor-Initiating Cells Prolong Survival in a Post-Surgery, Post-Chemotherapy Ovarian Cancer Relapse Model

Disease recurrence is the major cause of morbidity and mortality of ovarian cancer (OC). In terms of maintenance therapies after platinum-based chemotherapy, PARP inhibitors significantly improve the overall survival of patients with BRCA mutations but is of little benefit to patients without homolo...

Descripción completa

Detalles Bibliográficos
Autores principales: Harrington, Brittney S., Ozaki, Michelle K., Caminear, Michael W., Hernandez, Lidia F., Jordan, Elizabeth, Kalinowski, Nicholas J., Goldlust, Ian S., Guha, Rajarshi, Ferrer, Marc, Thomas, Craig, Shetty, Jyoti, Tran, Bao, Wong, Nathan, House, Carrie D., Annunziata, Christina M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352549/
https://www.ncbi.nlm.nih.gov/pubmed/32575908
http://dx.doi.org/10.3390/cancers12061645

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352549/
https://www.ncbi.nlm.nih.gov/pubmed/32575908
http://dx.doi.org/10.3390/cancers12061645

Ejemplares similares